{
    "organizations": [],
    "uuid": "c35f467e9c4aa76a769b6c4abdc6d5addab03e4e",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-cara-therapeutics-and-vifor-fresen/brief-cara-therapeutics-and-vifor-fresenius-medical-care-renal-pharma-enter-into-ex-u-s-licensing-agreement-idUSFWN1SU0D2",
    "ord_in_thread": 0,
    "title": "BRIEF-Cara Therapeutics And Vifor Fresenius Medical Care Renal Pharma Enter Into Ex-U.S. Licensing Agreement",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 23 (Reuters) - Cara Therapeutics Inc:\n* CARA THERAPEUTICS AND VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA (VFMCRP) ENTER INTO EX-U.S. LICENSING AGREEMENT TO COMMERCIALIZE KORSUVAâ„¢ INJECTION IN DIALYSIS PATIENTS WITH PRURITUS\n* CARA THERAPEUTICS INC - CARA ELIGIBLE FOR UP TO $470 MILLION IN REGULATORY AND COMMERCIAL MILESTONES\n* CARA THERAPEUTICS INC - VFMCRP TO COMMERCIALIZE KORSUVA INJECTION WORLDWIDE EXCEPT IN U.S., JAPAN AND SOUTH KOREA\n* CARA THERAPEUTICS INC - CARA RECEIVES UPFRONT PAYMENT OF $50 MILLION IN CASH AND AN EQUITY INVESTMENT OF $20 MILLION\n* CARA THERAPEUTICS INC - CARA IS ELIGIBLE TO RECEIVE TIERED ROYALTIES BASED ON NET SALES OF KORSUVA INJECTION IN LICENSED TERRITORIES\n* CARA THERAPEUTICS INC - CARA WILL SOLELY PROMOTE KORSUVA INJECTION IN ALL NON-FMC CLINICS IN U.S. AND RETAIN ALL PROFITS FROM THOSE SALES Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-23T18:11:00.000+03:00",
    "crawled": "2018-05-24T20:49:09.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "cara",
        "therapeutic",
        "inc",
        "cara",
        "therapeutic",
        "vifor",
        "fresenius",
        "medical",
        "care",
        "renal",
        "pharma",
        "vfmcrp",
        "enter",
        "licensing",
        "agreement",
        "commercialize",
        "injection",
        "dialysis",
        "patient",
        "pruritus",
        "cara",
        "therapeutic",
        "inc",
        "cara",
        "eligible",
        "million",
        "regulatory",
        "commercial",
        "milestone",
        "cara",
        "therapeutic",
        "inc",
        "vfmcrp",
        "commercialize",
        "korsuva",
        "injection",
        "worldwide",
        "except",
        "japan",
        "south",
        "korea",
        "cara",
        "therapeutic",
        "inc",
        "cara",
        "receives",
        "upfront",
        "payment",
        "million",
        "cash",
        "equity",
        "investment",
        "million",
        "cara",
        "therapeutic",
        "inc",
        "cara",
        "eligible",
        "receive",
        "tiered",
        "royalty",
        "based",
        "net",
        "sale",
        "korsuva",
        "injection",
        "licensed",
        "territory",
        "cara",
        "therapeutic",
        "inc",
        "cara",
        "solely",
        "promote",
        "korsuva",
        "injection",
        "clinic",
        "retain",
        "profit",
        "sale",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}